NAPRT and cancer: Indeed, cancer cells expressing high levels of NAPRT are resistant to NAMPT inhibitors and both the silencing of the gene and chemical inhibition of the enzyme overcome such resistance, suggesting that the coadministration of NAPRT and NAMPT inhibitors might improve anticancer therapies [2,11,12,13].